<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00768027</url>
  </required_header>
  <id_info>
    <org_study_id>2008-012</org_study_id>
    <nct_id>NCT00768027</nct_id>
  </id_info>
  <brief_title>Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System</brief_title>
  <acronym>HBOT</acronym>
  <official_title>Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HyperMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hyperbaric and Wound Care Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Long Beach Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Long Beach Memorial Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HyperMed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to define patient eligibility for hyperbaric oxygen therapy and to evaluate
      wound healing progression using a new hyperspectral imaging technology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this clinical study is to define patient eligibility for hyperbaric oxygen
      therapy (HBOT) and to evaluate wound healing progression during HBOT using a new
      hyperspectral imaging technology (OxyVu).
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Seeking additional funds
  </why_stopped>
  <start_date>August 2008</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>OxyVu measurements will be compared to transcutaneous oxygen measurements pre and post HBOT</measure>
    <time_frame>Days 1, 7, 14, 21, 4wks, and 2 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Wounds</condition>
  <eligibility>
    <study_pop>
      <textblock>
        18 to 85 years of age, males and females, and with and without diabetes and untreatable
        peripheral vascular disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  18 - 85 years of age

          -  Patients with wounds that meet the criteria for hyperbaric oxygen therapy (e.g.
             problem wound, diabetic foot ulcer, necrotizing soft tissue infections)

          -  Compromised Flap or Grafts.

        Exclusion criteria:

          -  Patients with poor cardiac output (EF &lt; 20%)

          -  Patients with severe obstructive pulmonary disease who don't qualify for HBOT

          -  Patients with untreated asthma who don't qualify for HBOT

          -  Patients utilizing supplemental oxygen and those on ventilators

          -  Patients on life support medications (pressors)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Niezgoda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hyperbaric &amp; Wound Care Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ian L Gordon, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Long Beach Healthcare System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael B Strauss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Long Beach Memorial Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Beach VA Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hyperbaric &amp; Wound Care Associates</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hypermed-inc.com</url>
    <description>Sponsor and OxyVu technology website</description>
  </link>
  <reference>
    <citation>Mathieu D. Role of hyperbaric oxygen therapy in the management of lower extremity wounds. Int J Low Extrem Wounds. 2006 Dec;5(4):233-5.</citation>
    <PMID>17088598</PMID>
  </reference>
  <reference>
    <citation>Niinikoski JH. Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry. World J Surg. 2004 Mar;28(3):307-11. Epub 2004 Feb 17. Review.</citation>
    <PMID>14961187</PMID>
  </reference>
  <reference>
    <citation>Niinikoski J. Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making. Wound Repair Regen. 2003 Nov-Dec;11(6):458-61.</citation>
    <PMID>14617286</PMID>
  </reference>
  <reference>
    <citation>Fife CE, Buyukcakir C, Otto GH, Sheffield PJ, Warriner RA, Love TL, Mader J. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1,144 patients. Wound Repair Regen. 2002 Jul-Aug;10(4):198-207.</citation>
    <PMID>12191001</PMID>
  </reference>
  <reference>
    <citation>Fife CE, Buyukcakir C, Otto G, Sheffield P, Love T, Warriner R 3rd. Factors influencing the outcome of lower-extremity diabetic ulcers treated with hyperbaric oxygen therapy. Wound Repair Regen. 2007 May-Jun;15(3):322-31.</citation>
    <PMID>17537119</PMID>
  </reference>
  <reference>
    <citation>Niezgoda JA, Mewissen M. The management of lower extremity wounds complicated by acute arterial insufficiency and ischemia. Ostomy Wound Manage. 2004 May;50(5A Suppl):1-11; quiz 12.</citation>
    <PMID>15366447</PMID>
  </reference>
  <reference>
    <citation>Deerochanawong C, Home PD, Alberti KG. A survey of lower limb amputation in diabetic patients. Diabet Med. 1992 Dec;9(10):942-6.</citation>
    <PMID>1478041</PMID>
  </reference>
  <reference>
    <citation>Frykberg RG. Guidelines for diabetic foot care. Foot Ankle Int. 2000 Jul;21(7):616.</citation>
    <PMID>10919631</PMID>
  </reference>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2008</study_first_submitted>
  <study_first_submitted_qc>October 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2008</study_first_posted>
  <last_update_submitted>June 2, 2009</last_update_submitted>
  <last_update_submitted_qc>June 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kevin Schomacker, PhD</name_title>
    <organization>HyperMed, Inc.</organization>
  </responsible_party>
  <keyword>hyperspectral imaging</keyword>
  <keyword>tissue oxygenation</keyword>
  <keyword>wounds</keyword>
  <keyword>wound healing</keyword>
  <keyword>prevention</keyword>
  <keyword>hyperbaric</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

